A study on male equivalent of polycystic ovary syndromes in male patients of acne grade 3 and 4.
- Conditions
- Health Condition 1: L700- Acne vulgaris
- Registration Number
- CTRI/2022/10/046452
- Lead Sponsor
- ICMR Indian council of medical research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1. Age more than equal to 18 years.
2. Male patient with acne grade 3 and 4.
3. Patient willing to sign informed consent form
1. Age less than 18 years.
2. Female patients of all age.
3. Male patients with acne grade 1 and 2.
4. Patient not willing to sign informed consent form.
5. Patients with underlying any endocrinological abnormality except type 2 diabetes mellitus which might interfere with study findings.
6. Patients taking oral corticosteroids taking for any medical conditions which might interfere with study findings.
7. Patients taking any hormonal therapy which might interfere with study results.
8. Patients taking any protein powders and sports medicines for body building which might interfere with study findings.
9. patients with underlying haematological and psychiatric disease.
10. Patients with underlying malignancy and paraneoplastic syndrome which might interfere with study results.
11. Major medical and surgical illness in past 4 months which might interfere with laboratory parameters in the study.
12. Patient taking herbal, homeopathic or any other alternative medicines which might interfere with study results.
13. Patients with any addictions.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.To estimate the hospital-based prevalence of ME-PCOS in male patients with acne grade 3 & 4. <br/ ><br>2. To estimate the hospital-based prevalence of other cutaneous markers of ME-PCOS in male patients with acne grade 3 & 4. <br/ ><br>3. To estimate hospital-based hormonal and metabolic derangements in male patients with acne grade 3 & 4. <br/ ><br>Timepoint: at baseline visit: single point cross sectional study <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1. To determine any corelation if any, between various clinical parameters of ME-PCOS and laboratory parameters (hormonal and metabolic). <br/ ><br>2. To determine any correlation between various clinical and laboratory parameters with the diet taken by the patients on regular bases. <br/ ><br>Timepoint: at baseline visit - single point cross sectional study